{"name":"VTBIO Co. LTD","slug":"vtbio-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxPeUx4N1VxLVVxc28zWUFqN2xxa0gwU2xfY2FldkpYcDBDNmFxR2V0azFwVXhGN0dNZFJTd3ZXVzU4cHYtbzZHUmNxVUhKandmdlhuOXM1UHRPbTV6VUs0NEt3WnlSYkZib2JaYTcwM1dOTmlSRzJId0E4bXF1M1FCcmJ6QzFQQ0VtZFVkWGN5aGM0X0FmY1RtQWEzZlNqWWtFQ0pmUHZvNU9SV3Q5LUdiekNaZmo0U2xZNkROM2lMQ05MM1REWkMtLUlYVDg3a29idE4zU3NPekFLRHJUeTZNRzhSSFkzQUhfV0VVbWRTcEtFclpHcUxVYXdXT2JINkhubFBNSzlJSldFMHEyLTliclQwTGpyVlNEWG5XRzdR?oc=5","date":"2025-08-12","type":"trial","source":"GlobeNewswire","summary":"Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ - GlobeNewswire","headline":"Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxNdTlUVV9UQ0M2bmowemt4UVFrZHlSbzRpMlZ0dnFfNVdOaTEwb1lPNnNiaHFYZFV5TVBJclBuT2dnZU9OeXhqV2Vtc2NabVpSZXY2bXdNblFvR2t2Sl93MGF0bkgxbzJCblZhWUxuckZXdTlxZExlQ2RiRGtHakNpU3dqNG5uaG4yNkUwYVVDM3hxVW1fbDdGdUdSRGxGanl3aHd1cmE2cWJuaUhOSlBtc242M2VnWnpFRm9EdGJLeGJNWk5EbWRWb19yWW9ob2g5T2dFRjNINlNRYm1fTG41dmxIWU9WQkxhUlJpVGZXcjY3enRJR1liTVIzcXZjZFVSTFVVbWp2alhuOXVLc1oyZ1dQajZlRWptMTVOTHdyRE02YWV1RWNNWXV3c1pxWjVmMXRjM3pubmthc0p5ZEVvMkpkOWZaZlB3TlE?oc=5","date":"2025-04-29","type":"trial","source":"GlobeNewswire","summary":"Phenylketonuria Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"Phenylketonuria Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxPMW5Cbm9rTXB2Z3FIVEpGcmwzM1dBZ3pQY3Z4aG1oTEJMZVhMWTBwdU5vWDdpdDhDM0VqaXFFd1VFMEtSOU5fSmF0X3VzM09WZEdhQkl3cWVGTDdrRVdjTGhIRU03akRPM29UX3VzTjVMLTFrb0xUZ3cwcWgyU2tnZ0tBTEQzNkl2U3lrR0hGWWd0bkhaSFRPWmhaOFNTYXBuM0Z1ZW1QMlBISnR6WHlNUlFJVUp0T3pMMDdvRHcySFVXVExhd0VvanEyNWZNTF9LdE9ERTZuRUpqVkdfUzhFMkJ4VDQ5OUpvX1Npd1ZyNHpjTnVqZFlNYkE5U1N3MlVXYzBpd2hlNA?oc=5","date":"2025-03-03","type":"pipeline","source":"GlobeNewswire","summary":"LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer’s Treatments| DelveInsight - GlobeNewswire","headline":"LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer’s Treatments| DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQaHVqSXFvY2lvRTMxZWFmU293SFBoVGpOeXZQSmxkT0NScTZWc3VTUmcwS3FKajRYS1o5UjZoSGRjZEVSNjhUYjF5a0o1N2ZQcDhSV25ZVUhEQ1dzdDR5VmhOaFl2TjNfOG1nNEZFQ0R0SzJuTzRrZU5YckExYUVnNWwwNnpQNXlqSC1zMDFORXE4Vk5mOHBsbnhEQVgxVVY1bkw5WC14aWdnU04zaWx6MVBHbUk3TWJ5bzV5eHdvSVR5SkRqaVR2c29MTDlnT2pPbi1yMDZ2aWlRTDdwWVpV?oc=5","date":"2024-10-30","type":"pipeline","source":"PR Newswire","summary":"Global Neurological Biomarkers Market to Surpass USD 16 Billion Mark by 2030 | DelveInsight - PR Newswire","headline":"Global Neurological Biomarkers Market to Surpass USD 16 Billion Mark by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxONGl0M2pkNFg2SFZMdEFnS0Y1LVRkY3AtNXBpYUtLWkR6WXNOWUl3MlpEeHBZOV9jcUlnWVRscVpDWkJ0OHAxRlFYNGxiRU5mWGNaTS1GWEZJUjJoMG9ZQjlyUVBBYW10WUgzRUJ4eWtVcjk0ZHJzNnlqRGU0VVhzci1sQ0ZYRE16Qjk3N3dCZ1prWVNtUE5XYWROMTBieUxYR3JxUkk1Tlg4N3kzX2Z4LTY5RkhDZUpHX09TTmsyTGlqN0lQN0Iwck1pMXRXS2ctSkJDRE11VExQWm1zcjVTZXlEano4VEpHd1FCRTlrSG5Wbjd1Sk9Ma2k1dGtXQ3kwM1ktejBuc0hOaU5tX2l3TG9ydFhfYXQ4NnN1WGtocGlvcEp6bWZpOEJCc3FfTTVyY3c?oc=5","date":"2024-10-28","type":"trial","source":"PR Newswire","summary":"Treg Cell-based Therapies Clinical Trial Pipeline Appears Robust With 51+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Treg Cell-based Therapies Clinical Trial Pipeline Appears Robust With 51+ Key Pharma Companies Actively Working in the T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxOU1d0ZnpQRW9kcEZ3dVdhdDNhc2FpZmRXSXFpeUpsNi1ZZVduZ1lRSGdfb1drRU4tMERkSWZvZGhJRW0yQmxtSEVzeEI3UWtTbDN4a3l5UnYtbXJKeEZFdWt0U21mVXZOSVBaNWxNQ2VTMk5BMjZwVWIxcHVxMnREaUZKb3c3cUpObU9BeTVKV3Y4THBOOUwyYzlQWnVKa1FQLUNjQ2hQd2tpREp1QzhhWnFuMTFNQjN4aVA5eUJIV3B1T2IxNFNMTVZSTnZ3XzY2c2p0cUR6T2ZJbFBhTWpZR2xOdGVlVWRlRmh5WkRqQWdmT3owU1dWakdRZ1J5VnR3bTVpaDB4WnljeHpvVm5UOHRtaE9Tc3g2WEd0eG5wZnhvMGZkNWk3WWI3TkJYRDM0VXJxdlhwSDZSMlk5emFGVmJJWUpubFluUHR5alVmVTk?oc=5","date":"2024-10-14","type":"trial","source":"GlobeNewswire","summary":"Tau Inhibitors Clinical Trial Pipeline Analysis - GlobeNewswire","headline":"Tau Inhibitors Clinical Trial Pipeline Analysis","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}